Momentum Trades

MomentumOptionsTrading.com Weekly Wrap for 5/30/11

9:00pm (EST)

1.  Market Summary  

2.  Rubicon (RBCN) – Bright Lights into the Future

3.   Polycom (PCLM) – Can You See Me Now?

4.  Earnings 

5.  Weekly Wrap Portfolio Update 

6.  Week Ahead

(To view the charts, please log into the Members Area and go to the Weekly Wrap Premium section)

= = = = = = = = = = = = = = =  

1.  Market Summary 

The market followed the same pattern as the week before with the bears winning the first part of the week while the bulls took the latter heading into Friday’s action.  Only this time instead of being even, the bulls needed a huge rally to get back to flat.

The Dow added 39 points on Friday to finish at 12,441.  The index reached a high of 12,483 and we were looking for a close above 12,500.  The blue-chips reached a low of 12,350 intraweek which has been our downside target during this current trading range.  There is additional support at 12,200-12,000 while resistance is at 12,500-12,600.  Should this zone be reached, the bulls will make a run at 12,800 again.  For the week, the Dow was down 70 points or 0.6%.  The Dow started the month of May at 12,810 so unless we have a huge rally on Tuesday, we will end the month negative, but the index is still up 7.5% YTD.  We are looking for the 50-day moving average to hold this week for the Dow.



The S&P 500 gained 5 points and closed at 1,331.  The index traded to a peak of 1,334 on Friday which is where we were looking for a close and held 1,325.  The next area of resistance will come in at 1,350 if this level is cleared this week with a shot at 1,375 on strength.  Support is at 1,325 for now with an additional layer at 1,300.  For the week, the S&P slipped 2 points, or 0.2%.  The index began the month of May at 1,363 and is up 5.8% for 2011.


The Nasdaq was higher by 14 points and settled at 2,797.  Tech traded to a top of 2,801 on Friday and just missed finishing above our 2,800 target.  The index closed below 2,750 on Tuesday and traded to a low of 2,739 by Wednesday.  We are looking for another run back to 2,850 with support coming in at 2,750 and then 2,725-2,700.  For the week, the Nasdaq dropped a six-pack, or 0.2%.  Tech ended April at 2,873 and is up 5.4% for the year.


The S&P 500 Volatility Index (^VIX, 15.98, down 0.11) traded to 20 on Monday and we said if this level was penetrated we would test our downside targets.  The good news was that both the VIX and our downside targets held. 


= = = = = = = = = = = = = = = 

2.  Rubicon (RBCN) – Bright Lights into the Future

Rubicon (RBCN, $22.95, down $0.17) makes monocrystalline sapphire and other crystalline products for LEDs, radio frequency integrated circuits, blue laser diodes, optoelectronics, and other optical applications.  As the only vertically integrated manufacturer of high quality, large diameter sapphire wafers in large volumes, it is the provider of choice for manufacturers of LEDs worldwide.

As demand for energy efficiency increases, light-emitting diodes demand will grow.  However, the stock has not done well over the past year, mainly due to high short interest and to increased competition from the likes of Samsung and LG.  But demand for sapphire substrates used in light emitting diodes (LEDs) is expected to grow strongly, offsetting further price declines.  LEDs take far less power to produce an equivalent amount of light when compared to an incandescent light bulb.  Thus, they are both environmentally friendly and favored when trying to cut energy consumption.

Short interest in the stock has fallen from 65% on November of last year to 51%.  Although high, the short interest has fallen, often perceived as bullish.  Plus institutional holding is high at 97%, a potentially bullish sign. Fidelity Growth Fund is the largest mutual fund owner with a 6.36% stake.  Since Fidelity is known to have great track records, it may be wise to follow the institution’s pick.  The high short interest also offers a chance for a short squeeze in the stock, driving it higher. 

The company’s 5-year sales growth increased an average of 36.52%.  Gross margin was 63% in the 1st quarter.  The company estimates 2nd quarter revenue will be between $40 million and $43 million.  Gross margin is expected to fall to the high 50% range due to pricing pressure in its primary sapphire wafer market.  Earnings are expected to come out between $0.82 and $0.86.  Analysts estimate earnings of $0.74 on revenue of $42.90 million.  Thus, analysts’ earning estimates is below the company’s expectations, while revenue estimates is in the high end of the expected revenue range.

Over the last four quarters, the company beat earnings estimates by an average of 22.5%.  The graphs below show revenue and earnings trend with next quarter estimates plotted at the end.  Earnings are non-GAAP.

Revenue has increased in a near parabola over the quarters, but last quarter showed a slowdown from the trend.  The year over year graph shows that revenue growth jumped in the 1st quarter compared to that of last year.  2nd quarter is estimated to see a similar jump.  Thus, the odds say that the company will meet or beat revenue estimates.

The earnings trend looks similar to the revenue graph, but the sudden fall in earnings looks too weak a forecast.  2nd quarter year-over-year quarterly earnings growth is expected to grow from that of the previous year, but at a slower pace than that seen in the 1st quarter.  Thus, the odds say that the company will beat on earnings.

Although earnings are not due till August 1st, upgrades are possible in the near future, driving up the stock.  One big plus, on May 23rd, Chief Executive Officer Raja Parvex purchased 2,000 shares at a price of $22.03.  This is bullish.

From the graph below, the stock is right on its 200-day moving average.  Since the stock is heading up from below the 200-dma, this line could serve as a breakout point.  The resistance and support lines correspond with the stock’s Bollinger Bands, meaning that price will have a hard time crossing these lines in the near future.  Resistance line is at $28, and support line is at $20.  The stock is currently in the lower half of that range, at $22.95. 


The technicals give a bullish cross for the stochastic %K and %D and a buy signal in the MACD (Moving Average Convergence/Divergence).  The last time this happened, the stock started a $10 bull run to the resistance line, indicated by the purple vertical line.  Further, all the other technicals are in oversold territory, strengthening the buy signal.  Other times when the technicals were at similar levels, indicated by the two vertical light blue lines, the stock also rose.  However, the cross by the stochastic %K and %D was not as low as that of the vertical purple line, perhaps leading to the shorter bullish run.

The 50-day moving average (MA) could cause a slight pause in the stock.  The direction also often shows the stock’s momentum.  This is the only negative, since it just recently turned downward.  However, there is a lag in moving averages.  But notice that the 50-day MA almost always crossed through the midpoint of a bull rally.  Thus, perhaps the stock will rise again to cross the 50-day MA.

We like this stock a lot but we are going to wait a week or two before we add it to our portfolio in case shares come back down to $20.  

 = = = = = = = = = = = = = = = 

3.  Polycom (PCLM) – Can You See Me Now?

Companies are to shifting more and more to teleconferencing.  That is good news for Polycom (PCLM, $57.37, up $0.65), which is shown in the graph below.

On May 25th, the stock jumped 4% on double its usual volume.  This is one bullish sign.

Going forward, the company has several events that could serve as catalyst to drive the stock higher.  On June 3rd, it will be speaking at the Bernstein Strategic Decisions Conference.  On June 7th, it will be presenting at the RBC Capital Markets’ Communications Technology Investor Day.  On June 16th, Michael R. Kourey, CFO, will be speaking at the William Blair Growth Stock Conference.  And on June 21st, Andy M. Miller, President & CEO, will be speaking at the NASDAQ OMX 26th Investor Program. 

If any of these events turn out good, the stock could push higher.  We are betting that some or all of the events will turn out good.

The company managed to grow their revenue by the same amount every quarter, as shown in the graph above.  And the year-over-year quarterly revenue graph shows that 1st quarter revenue growth increased slightly compared to that of the previous year.  2nd quarter revenue growth is estimated to stay the same as the previous year.  Thus, the odds are that it will meet or beat on revenues.  The company forecasts a strong quarter as it benefits from its partnerships with companies like Microsoft (MSFT) and from business disruptions at rival Cisco (CSCO).

Earnings, however, show a dramatic slowdown last quarter and a slight increase estimated for the 2nd quarter.  But the year-over-year quarterly earnings graph shows that 1st quarter earnings growth increased dramatically compared to that of the previous year.  2nd quarter earnings growth is estimated to also increase from that of the previous year, but by not as much.  Thus, earnings may have a hard time beating estimates, but the odds are that it will at least meet them.

As the graph on the first page shows, the stock fell on April 28th due to index downward pressure, we must also check the index to make sure the stock will go up.  If all other stocks fall, it will have a hard time rising.

The graph of the S&P 500, pictured above, shows a bullish triangle and bullish technicals.  The three times when the technicals were at similar levels, the index rose.  Plus, the stochastic %K and %D and the RSI are both near oversold levels.  Thus, the index doesn’t look as if stocks will fall, and therefore clearing the way for a rise in PLCM.

For the stock, it is right on its 20-day moving average.  This line could serve as a breakout point.  Plus, the stock has carved out a bullish swing flag.

The resistance and support lines correspond with the stock’s Bollinger Bands, meaning that price will have a hard time crossing these lines in the near future.  Resistance line is currently at $60, and support line is currently at $54, but both lines climb at a rate of 11 cents a day.  The stock is currently at $57.37. 

All the technicals are neither overbought nor oversold, but the last time the technicals were at similar levels, the stock started its current 6-month uptrend.

Using this data and the 11-cent per day slope of the resistance line, we get a resistance price of $61.65 by mid-June.  The June 60 calls (PLCM110618C00060000, $0.70, up $0.03) might be worth a gamble but a better play might be the July 62.50 calls (PLCM110716C00062500, $1.25, up $0.10).    

 = = = = = = = = = = = = = = = 

4.  Earnings 

The companies in BOLD, we are looking at as possible trades and we may list call or put options on them in our Daily Newsletter.  If they become official recommendations, we sent out Trade Alerts or include them in our 9am and 1pm updates that come out during the week.  The first set of companies report before the bell that day, the second set after the market closes.  (Quotes are as of Friday’s close, 5/27/11). 

MONDAY
 
Market closed for Memorial Day
 
TUESDAY
 
Bridgford Foods (BRID, $8.62, down $0.27), China Automotive Systems (CAAS, $7.65, down $0.14), Copart (CPRT, $46.46, down $0.15), Phillips Van Heusen (PVH, $66.58, up $0.39)
 
WEDNESDAY
 
Coldwater Creek (CWTR, $1.92, up$0.05), Daktronics (DAKT, $10.10, down $0.11), Dollar General (DG, $34.66, up $0.77), Vera Bradley (VRA, $50.05, up $0.44)
 
THURSDAY
 
Cascade (CASC, $40.03, up $1.45), Charming Shoppes (CHRS, $3.98, up $0.13), China Medical Technologies (CMED, $10.13, up $0.04), Cooper Companies (COO, $74.39, down $0.08), Diamond Foods (DMND, $75.05, up $0.72), Exide Technologies (XIDE, $9.76, up $0.14), Fresh Market (TFM, $40.54, down $0.08), Joy Global (JOYG, $89.20, up $0.75), Saic (SAI, $17.27, down $0.09), Uti Worldwide  (UTIW, $21.73, down $0.09), Verifone Systems (PAY, $48.16, up $0.93)
 
FRIDAY
 
American Woodmark (AMWD, $20.22, down $0.54), Blyth (BTH, $44.69, down $0.19)

= = = = = = = = = = = = = = = 

5.  Weekly Wrap Covered Call Portfolio Update (Closing prices as of 5/27/11)

Vivus (VVUS, $8.84, up $0.07)

June 8 calls (VVUS110618C00008000, $0.85, flat)

Original Entry Price:  $7.93 (5/11/11)

Lowered Price from Selling Options: $7.43

Exit Target: $10+

Return: 19%

Stop Target: None


Action:  Vivus hit a high of $9.07 on Thursday as its erectile dysfunction drug, Avanafil, continues to garner attention.  The drug is currently in Phase 3 trials and could gain approval sometime over the next 3-6 months.  Of course, we are more interested in Qnexa, its diet drug, but Avanafil will be the company’s first drug to market that will bring in revenue.


We recommended buying the stock at $7.93 on 5/11/11 and for every 100 shares to sell the June 8 calls for 50 cents.  This lowered the cost basis to $7.43. 

If shares are called away by mid-June at $8 the trades makes 8% in less than 5 weeks.


AKS Steel Holding (AKS, $15.29, up $0.25)

Original Entry Price:  $15.93 (5/2/11)   

Lowered Price from Selling Options: $15.43

Exit Target: $20+

Return: -1%

Stop Target: None

Action:  AKS Steel has a big week as shares added 6%.  Shares held strong support at $14 (black line).  We are looking for a run back near $16 before selling another call option.  The July 16’s are at 55 cents but we would like to get a little more premium before selling them.

We recommended buying the stock at $15.93 on 5/2/11 and for every 100 shares to sell the May 16 calls for 50 cents.  This lowered the cost basis to $15.43.


American Capital (ACAS, $9.80, down $0.01)

June 10 calls (ACAS110618C00010000, $0.20, flat)

Original Entry Price:  $9.73 (4/19/11)   

Lowered Price from Selling Options: $9.23

Exit Target: $15+

Return: 6%

Stop Target: None

Action:  American Capital held support last week and bounced.


We recommended buying the stock at $9.73 on 4/19/11 and for every 100 shares to sell the June 10 call for 50 cents.  This lowered the cost basis to $9.23. 

If shares are called away by mid-June at $10 the trades makes 8%.   

 

Cisco Systems (CSCO, $16.46, up $0.21)

Original Entry Price:  $17.14 (3/17/11)   

Lowered Price from Selling Options: $16.58

Exit Target: $20+

Return: -1%

Stop Target: None

Action:  Cisco hit a 52-week low of $16.11 last week.  The stock trades at just above 12x earnings and yields 1.5%.  When there is a dividend payment, you will collect that as well to lower your cost basis since you own the stock.  We are still watching the July 16 calls (CSCO110716C00016000, $0.75, up $0.10) and would like to get $1 for them before selling.

The stock is well below its 50-day MA and we are looking to sell another call at $17 for Cisco.


We recommended buying the stock at $17.14 on 3/17/11 and for every 100 shares to sell the May 18 call for 56 cents.  This lowered the cost basis to $16.58. 


Spreadtrum Communications (SPRD, $18.83, down $0.16)  

Entry Price:  $23.45 (2/7/11)

Lowered Price from Selling Options: $21.48

Exit Target: $30

Return: -12%

Stop Target: None

Action:  We are looking to sell another call once shares get back over $21-$22.  There is strong support at current levels.


Shares opened at $23.43 on 2/7/11 and the March calls could have been sold for 95 cents.  This lowered the cost basis to $22.48.

On 4/11/11 we recommended selling the May 22.50 call option for $1.00 which lowered the cost basis to $21.48.


DryShips (DRYS, $3.73, up $0.02)

January 2012 7.50 call (DRYS120121C00007500, $0.10, flat)   

Entry Price:  $5.25 (1/03/11)  

Lowered Price from Selling Options: $4.60

Exit Target: $8

Return: -17%

Stop Target: None

Action:  Continue to hold. 

DryShips opened at $5.37 on 1/3/11 and shares were at $5.25 shortly after the bell.  The January call options could have been sold for 65 cents which lowered the cost basis to $4.60.  

If shares are over $7.50 by January 2012, the stock will be “called away” and the trade will make over 60%.


Seattle Genetics (SGEN, $19.52, up $0.22)

June 17.50 calls (SGEN110618C00017500, $2.15, up $0.15) 

Entry Price:  $15.50 (12/27/10)  

Lowered Price from Selling Options: $13.85

Exit Target: $20

Return: 41%

Stop Target: None

Action:  Seattle Genetics added another 50 cents for the week and hit a new 52-week high of $19.59 in the process.       

We have told you about the company’s drug pipeline which has 2 possible applications currently being looked at by the FDA for approval but there is more to their story.  The company also gets licensing fees from other drug makers who use their antibody-drug conjugate (ADC) technology which has brought in more than $145 million so far.

We have been saying shares are headed to $20+ (red circle) and we would love to see a close above this level for the week.  (Note:  We also have an ongoing trade in our Daily newsletter for Seattle Genetics that is up 63%).


Seattle Genetics opened at $15.80 and shares were at $15.50 at 10am on 2/27/10.  The March 17.50 call option could have been sold for 90 cents.  This lowered the cost basis to $14.60. 

On 4/4/11, the June calls could have been sold for 75 cents which lowered the cost basis to $13.85.  If shares are called away at $17.50 in mid-June the trade will make 26%.  


Dendreon (DNDN, $42.38, up $0.47)  

Entry Price:  $41.96 (9/13/10)  

Lowered Price from Selling Options: $36.61

Exit Target: $45

Return: 16%

Stop Target: None

Action:  Shares of Dendreon are right at the top of their trading range so we are going to hold off on selling another call option for now.  There could be a breakout coming so we want to maximize our gains. 


Dendreon opened at $41.96 and you could have sold the October 45 call option for $1.30 on 9/13/10.  This lowered the cost basis to $40.66.

On 11/11/10 we sold the December 40 call option for $1.75 which lowered our cost basis to $38.91.

On 12/20/10 we sold the February 39 call option for $1.50 which lowered our cost basis to $37.41.

On 4/11/11 we recommended selling the May 43 call options for 80 cents.  This lowered the cost basis to $36.61.

 

= = = = = = = = = = = = = = = 

6.  Week Ahead

We have a big week for economic news so let’s see what’s on tap.

For Tuesday, the market will digest the latest Case-Shiller 20-City Index report before the open with the Chicago PMI due 15 minutes after the open.  At 10am, Consumer Confidence will released.

On Wednesday, the MBA Mortgage Index is due out along with the Challenger Jobs Cuts report before the bell.  Additionally, the ADP Employment Change numbers will be released before the open.  At 10am, the market gets two more updates; the ISM Index and Construction Spending numbers.  Finally, at 3pm, Auto Sales and Truck Sales will be released. 

Thursday starts off with Initial Claims and Continuing Claims as Wall Street will be looking for a continued improvement in jobs.  Shortly after the open, Factory Orders and Crude Inventories will be released.

Friday will big as we get May Nonfarm Payrolls and the Unemployment Rate along with Hourly Earnings and the Average Workweek numbers.  After the bell, the ISM Services report will be released.

]]>

Scroll to Top